Home » FDA Approves Nexus’ Emerphed Pre-Filled Syringes
FDA Approves Nexus’ Emerphed Pre-Filled Syringes
The FDA has approved Nexus Pharmaceuticals’ Emerphed (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes to treat hypotension during anesthesia.
The device is the first 10 mL ephedrine sulfate injection pre-filled syringe to be approved by the agency.
Nexus first received FDA’s approval for Emerphed injection in a ready-to-use vial in April 2020 and gained a patent covering certain applications of the ready-to-use injection in August 2021.
The approved product is available immediately in the U.S. in cartons of ten syringes.
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct